Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Eric Simoes to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Eric Simoes has written about Antibodies, Monoclonal, Humanized.

 
Connection Strength
 
 
 
0.281
 
  1. Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
    View in: PubMed
    Score: 0.048
  2. Feltes TF, Simoes E. Palivizumab prophylaxis in haemodynamically significant congenital heart disease. Arch Dis Child. 2005 Aug; 90(8):875-7; author reply 875-7.
    View in: PubMed
    Score: 0.042
  3. Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis--the story so far. Respir Med. 2002 Apr; 96 Suppl B:S15-24.
    View in: PubMed
    Score: 0.034
  4. Simoes EA. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res. 2002; 3 Suppl 1:S26-33.
    View in: PubMed
    Score: 0.033
  5. Simoes EA. Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med. 2001 Mar; 163(3 Pt 2):S14-7.
    View in: PubMed
    Score: 0.031
  6. Simoes EA. Immunoprophylaxis of respiratory syncytial virus infection. Indian Pediatr. 2000 Mar; 37(3):243-7.
    View in: PubMed
    Score: 0.029
  7. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999 Sep 04; 354(9181):847-52.
    View in: PubMed
    Score: 0.028
  8. Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics). Pediatr Ann. 1999 Aug; 28(8):507-14.
    View in: PubMed
    Score: 0.028
  9. Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease. Antimicrob Agents Chemother. 1999 May; 43(5):1183-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)